Drug Trial Radar · NCT02040350
Is the WHO Recommended Dose of Pralidoxime Effective in the Treatment of Organophosphorus Poisoning?
Last checked: Nov 19, 2026Latest source record: Jan 20, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
100
Actual
Start
Apr 2012
Primary completion
Aug 2013
Study completion Nov 2013
Sponsor
- Lead sponsor
- Sheri Kashmir Institute of Medical SciencesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 20, 2014
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Triple (care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 14 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the effectiveness of Pralidoxime, a drug used for treatment of pesticide poisoning (Organophosphorous poisonings)
Conditions
- Deaths
Interventions
PralidoximeDrug
Pralidoxime was compared to placebo to study the effects of the drug on mortatlity
Primary outcomes
What the sponsor says the trial is designed to measure.
- mortality rateTime frame: upto one year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sheri kashmir insititute of medical sciences
Srinagar, Srinagar Kashmir, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.